MRD Status Can Help Guide Treatments in NPM1-Mutated AML : v

Molecular minimal residual disease status may offer clues as to which patients with acute monocytic leukemia will benefit from certain therapies.

Related Keywords

London , City Of , United Kingdom , United States , American , , American Society Of Hematology Annual Meeting , Hematology Annual , Jad Othman , Leukemia , Aml , Cash , American Society Of Hematology ,